Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Sudden late onset of clozapine-induced agranulocytosis.

Patel NC, Dorson PG, Bettinger TL.

Ann Pharmacother. 2002 Jun;36(6):1012-5.

PMID:
12022904
2.
3.

Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.

Raveendranathan D, Sharma E, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN.

Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):574.e5-6. doi: 10.1016/j.genhosppsych.2012.07.001. Epub 2012 Aug 15.

PMID:
22902258
4.

Clozapine-induced agranulocytosis treated with granulocyte macrophage colony stimulating factor.

Oren R, Granat E, Shtrussberg S, Matzner Y.

Br J Psychiatry. 1993 May;162:686-7.

PMID:
8149123
5.

Re: Cytokines and agranulocytosis induced by clozapine.

Malek-Ahmadi P.

Can J Psychiatry. 1996 Nov;41(9):603. No abstract available.

PMID:
8946085
6.

Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.

Kolli V, Denton K, Borra D, Pulluri M, Sharma A.

Psychooncology. 2013 Jul;22(7):1674-5. doi: 10.1002/pon.3209. Epub 2012 Oct 12.

PMID:
23059755
7.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.

Barnas C, Zwierzina H, Hummer M, Sperner-Unterweger B, Stern A, Fleischhacker WW.

J Clin Psychiatry. 1992 Jul;53(7):245-7.

PMID:
1639744
8.
9.

Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.

Hägg S, Rosenius S, Spigset O.

Int Clin Psychopharmacol. 2003 May;18(3):173-4.

PMID:
12702898
10.

White blood cell monitoring during long-term clozapine treatment.

Cohen D, Monden M.

Am J Psychiatry. 2013 Apr;170(4):366-9. doi: 10.1176/appi.ajp.2012.12081036.

PMID:
23545791
11.
12.

Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.

Hazewinkel AW, Bogers JP, Giltay EJ.

Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):576.e11-2. doi: 10.1016/j.genhosppsych.2013.01.002. Epub 2013 Feb 6.

PMID:
23395419
13.

Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Whiskey E, Taylor D.

CNS Drugs. 2007;21(1):25-35. Review.

PMID:
17190527
14.
15.

Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.

Schulte P.

Ann Pharmacother. 2006 Apr;40(4):683-8. Epub 2006 Mar 7.

PMID:
16595571
16.

Filgrastim treatment of three patients with clozapine-induced agranulocytosis.

Lamberti JS, Bellnier TJ, Schwarzkopf SB, Schneider E.

J Clin Psychiatry. 1995 Jun;56(6):256-9.

PMID:
7539786
17.

The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF).

Chengappa KN, Gopalani A, Haught MK, McChesney K, Baker RW, Schooler NR.

Psychopharmacol Bull. 1996;32(1):111-21.

PMID:
8927660
18.

[Agranulocytosis caused by clozapine: the importance of leukocyte monitoring and efficacy of hematopoietic growth factors].

van Melick EJ, Touw DJ, Haak HL.

Ned Tijdschr Geneeskd. 1995 Nov 25;139(47):2437-40. Review. Dutch.

PMID:
8524426
19.

Blood dyscrasias in clozapine-treated patients in Italy.

Lambertenghi Deliliers G.

Haematologica. 2000 Mar;85(3):233-7.

20.

Clozapine treatment after agranulocytosis induced by classic neuroleptics.

Bauer M, Mackert A.

J Clin Psychopharmacol. 1994 Feb;14(1):71-3.

PMID:
7908676

Supplemental Content

Support Center